While some notice a natural glow after just a few sessions, others may take a few weeks to experience visible skin lightening or improved energy levels
Exclusion criteria included patients younger than 18 years, any patient with a death date on or before the index date (deceased patients at baseline), individuals with pre-existing conditions known to impact gastrointestinal GI functions, e.g., major GI or abdominal surgeries, connective tissue disorders (e.g., amyloidosis, Ehlers-Danlos syndrome, Sjgrens syndrome), inflammatory bowel diseases, and other major systemic or GI conditions (cystic fibrosis, intestinal failure, etc.) predisposing to SIBO
CPL is supported by an American Kidney Funds Clinical Scientist in Nephrology Award
If you or a loved one experienced sudden vision changes while taking a GLP-1 drug like Ozempic, you may have a case
Here is a quick breakdown of where the key next-generation candidates currently stand: Retatrutide (Eli Lilly): Phase 3 trials are actively studying cardiovascular outcomes alongside weight loss
If you need reliable intake support, look elsewhere
